Provided by Fialdini Einsfeld Advogados
The bulk of Fialdini Einsfeld Advogados' Life Sciences practice is comprised of highly complex litigation cases and strategic advice covering the full spectrum of life sciences issues. The firm acts on strategic litigation cases, including civil, administrative and commercial matters and is able to act on the lower and superior courts of Brazil.
A full array of life sciences issues is covered, including clinical trials, termination of distribution contracts, patent infringements and price regulations. The firm has a particularly strong presence in the pharmaceutical, animal health and consumer goods in the health sector.
Fialdini Einsfeld's dedicated team is noted for its life sciences litigation practice. The team represents pharmaceutical companies in disputes about termination of distribution contracts, patent infringements and clinical trials, among others. Additionally, the team has experience advising on price regulation proceedings and technology transfer agreements, being seasoned representing clients before ANVISA and CMED.
A client says: "They have a solid knowledge regarding ANVISA, CMED and public law. They are always available and are well articulated in the market."
Fialdini Einsfeld advised Allergan on the voluntary recall of its BIOCELL breast implants and defended the company in lawsuits brought by customers across Brazil.
Litigator Pedro Fialdini is well regarded for his track record of success in life sciences disputes. A client says: "Pedro is aware of all the peculiarities involving our lawsuits and pre-litigation issues, working with us to solve difficult matters."
Associate-to-watch Thiago Albigiante assists clients with a range of issues. A client says: "Thiago achieves great results, besides working with us to solve difficult matters in a global perspective."